Targeted release in the small intestine
Iron absorption occurs in the duodenum, a section of the small intestine immediately after the stomach. Iron supplements are often provided with slow release technology but may not dissolve in time for absorption to occur in the duodenum. Any unabsorbed iron can lead to the production of free radicals and reactive oxygen species. Our iron formulation uses targeted release technology to deliver iron directly to the duodenum for maximum absorption.
Gentle on the stomach
Standard iron supplements are often associated with unpleasant side effects, including nausea and constipation. We use the well tolerated chelated iron bisglycinate form which binds iron to glycine, preventing irritation of gut tissue and minimising the unpleasant side effects of iron supplements. Targeted release technology releases iron in the small intestine, further preventing irritation in the stomach.
Meaningful dose without overloading the body
Excess iron can be harmful to health, with gastrointestinal upset more likely to occur when supplementing high dose iron. Iron Bisglycinate delivers a meaningful 20mg dose to support iron status without upsetting homeostasis. Additionally, absorption of iron in the bisglycinate form is regulated by haemoglobin and ferritin levels in the blood and is less likely to cause iron overload. Simply take one tablet in the morning on an empty stomach.
Energy support
Concentration & immune support
Blood & cellular health
Be kind to your health
Dr Jav Nazemi
CEO & Co-Founder